The proposed rule amendment is intended to add an additional entity as a provider for continuing education for prescribing controlled substances.  

  •  

    DEPARTMENT OF HEALTH

    Board of Medicine

    RULE NO.:RULE TITLE:

    64B8-13.008Requirement for Continuing Education Course on Prescribing Controlled Substances

    PURPOSE AND EFFECT: The proposed rule amendment is intended to add an additional entity as a provider for continuing education for prescribing controlled substances.

    SUMMARY: Addition of MagMutual Insurance Company as a provider for continuing education for prescribing controlled substances.

    SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

    The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

    The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board concluded that this rule change will not have any impact on licensees and their businesses or the businesses that employ them. The rule will not increase any fees, business costs, personnel costs, will not decrease profit opportunities, and will not require any specialized knowledge to comply. This change will not increase any direct or indirect regulatory costs. Hence, the Board determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

    Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

    RULEMAKING AUTHORITY: 456.0301(2) FS.

    LAW IMPLEMENTED: 456.0301 FS.

    IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Claudia Kemp, J.D., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin # C03, Tallahassee, Florida 32399-3253, or by email at claudia.kemp2@flhealth.gov.

     

    THE FULL TEXT OF THE PROPOSED RULE IS:

     

    64B8-13.008 Requirement for Continuing Education Course on Prescribing Controlled Substances.

    (1) No change.

    (2) The Board approves the controlled substance prescribing courses offered by the Florida Medical Association, the Florida Academy of Family Physicians, the Florida College of Emergency Physicians, Baptist Health South Florida/Quality Network, InforMed, Florida Psychiatric Society, and Florida Osteopathic Medical Association, and MagMutual Insurance Company, for the purpose of meeting this continuing education requirement.

    (3) – (4) No change.

    Rulemaking Authority 456.0301(2) FS. Law Implemented 456.0301 FS. History–New 7-15-18, Amended 9-10-18,                      .

     

    NAME OF PERSON ORIGINATING PROPOSED RULE: Rules/Legislative Committee, Board of Medicine

    NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Medicine

    DATE PROPOSED RULE APPROVED BY AGENCY HEAD: August 7, 2020

    DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: August 27, 2020

Document Information

Comments Open:
9/11/2020
Summary:
Addition of MagMutual Insurance Company as a provider for continuing education for prescribing controlled substances.
Purpose:
The proposed rule amendment is intended to add an additional entity as a provider for continuing education for prescribing controlled substances.
Rulemaking Authority:
456.0301(2) FS.
Law:
456.0301 FS.
Contact:
Claudia Kemp, J.D., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin # C03, Tallahassee, Florida 32399-3253, or by email at claudia.kemp2@flhealth.gov.
Related Rules: (1)
64B8-13.008.